New insights into treating Parkinson's from yeast, stem cell experiments
from The Boston Globe
A team of scientists at the Cambridge-based Whitehead Institute for Biomedical Research have identified a compound that can reverse some of the toxicity that occurs in brain cells created from Parkinson’s disease patients’ stem cells. The work, described in a pair of studies published in the journal Science, is still very early — the researchers aren't even using the word "drug" when describing the small molecule that jumped out when they screened a chemical library of about 200,000 compounds.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063